1. 1-24 of 214 1 2 3 4 5 6 7 8 9 »
    1. Samuel E. Navarro Appointed to BioSig Board of Directors

      Samuel E. Navarro Appointed to BioSig Board of Directors

      Santa Monica, CA, June 25, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing technology platform designed to address an unmet need for the electrophysiology (EP) marketplace, today appointed Samuel E. Navarro to its Board of Directors...

      Read Full Article
    2. Arbutus Appoints William Collier as Next President & CEO

      Arbutus Appoints William Collier as Next President & CEO

      WARMINSTER, Pa., June 17, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced the appointment of William H. Collier as President and Chief Executive Officer, effective June 24th. Mr. Collier has also been appointed as a member of the Board of Directors of Arbutus ...

      Read Full Article
    3. Methode Electronics, Inc. Adds Former Brunswick Chairman and CEO Mark Schwabero and Healthcare Executive Bruce Crowther to its Board of Directors

      Methode Electronics, Inc. Adds Former Brunswick Chairman and CEO Mark Schwabero and Healthcare Executive Bruce Crowther to its Board of Directors

      CHICAGO, June 14, 2019 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application specific products and solutions, announced today the election of Mark Schwabero and Bruce Crowther as directors of the Company...

      Read Full Article
    4. Cerecor Appoints Keith Schmidt to its Board of Directors

      Cerecor Appoints Keith Schmidt to its Board of Directors

      (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in pediatrics and neurology, today announced the appointment of Keith Schmidt to its Board of Directors effective immediately.  Mr. Schmidt joins the Cerecor Board as a member of the Audit Committee, the Compensation Committee, and an independent director serving a term ending at the 2019 Annual Meeting...

      Read Full Article
    5. Nancy Erba Joins PDF Solutions Board of Directors

      Nancy Erba Joins PDF Solutions Board of Directors

      SANTA CLARA, Calif., June 03, 2019 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (NASDAQ: PDFS), a leading provider of differentiated data and analytics solutions to the semiconductor and electronics industries, today announced that Nancy Erba has joined the Company’s Board of Directors effective June 3, 2019.  Ms. Erba will also serve on the Company’s Audit and Corporate Governance Committee...

      Read Full Article
    6. Landec Appoints Board Member Dr. Albert D. Bolles as CEO to Focus on Operational Excellence and Profitable Growth

      Landec Appoints Board Member Dr. Albert D. Bolles as CEO to Focus on Operational Excellence and Profitable Growth

      SANTA CLARA, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Curation Foods Inc. and Lifecore Biomedical Inc., today announced that its board of directors has named board member Albert D. Bolles, Ph.D. as chief executive officer effective immediately, following the resignation of Molly Hemmeter for personal reasons. Dr. Bolles has served on Landec’s board since May 2014. He has a proven track record of visionary leadership and building teams across R&D, technical innovation, quality and supply chain and delivering results through operational excellence, enabling commercial ...

      Read Full Article
    7. Kevin Mansell Elected to Fossil Group, Inc. Board of Directors

      Kevin Mansell Elected to Fossil Group, Inc. Board of Directors

      RICHARDSON, Texas, May 22, 2019 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (Nasdaq GS: FOSL) (the “Company”) announced the election of Kevin Mansell to its Board of Directors, effective May 22, 2019.  With Mr. Mansell’s election, the Company’s Board of Directors consists of nine members, including eight independent directors and one current member of senior management...

      Read Full Article
    8. Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors

      Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors

      Santa Monica, CA, May 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that Dr. Jerome B. Zeldis agreed to re-join the Company as an Independent Director, effective immediately...

      Read Full Article
    9. Pacific Mercantile Bancorp Announces Election of Shannon F. Eusey and Michele S. Miyakawa to Board of Directors

      Pacific Mercantile Bancorp Announces Election of Shannon F. Eusey and Michele S. Miyakawa to Board of Directors

      COSTA MESA, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- Pacific Mercantile Bancorp (Nasdaq: PMBC, the “Company”), the holding company of Pacific Mercantile Bank (the “Bank”), a wholly owned banking subsidiary, today announced the election of Shannon F. Eusey and Michele S. Miyakawa to the board of directors of Pacific Mercantile Bancorp at the Company’s annual of meeting of shareholders on May 15, 2019.  Ms. Eusey and Ms. Miyakawa are new additions to the Company’s board of directors and will also serve on the board of directors of Pacific Mercantile Bank...

      Read Full Article
    10. NewBridge Global Ventures Appoints Eric Baum to Board of Directors

      NewBridge Global Ventures Appoints Eric Baum to Board of Directors

      ALAMEDA, CA, May 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – NewBridge Global Ventures, Inc. (“NewBridge” or the “Company”), (OTCQB: NBGV), a vertically integrated processing company focused on the legal and regulated cannabis and hemp industries, today announced the appointment of Eric Baum to its Board of Directors. The appointment is effective immediately and increases the Company’s Board to six directors, three of which are independent...

      Read Full Article
    11. MeiraGTx Appoints Nicole Seligman to Board of Directors

      MeiraGTx Appoints Nicole Seligman to Board of Directors

      LONDON and NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment of Nicole Seligman to its Board of Directors. Ms. Seligman is an accomplished leader with extensive executive, legal, compliance and governance experience...

      Read Full Article
    12. Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors

      Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors

      SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) --  Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and first-in-class therapeutics for the treatment of pain and inflammatory diseases, today announced the completion of its merger with Alliqua BioMedical, Inc...

      Read Full Article
    13. Adverum Biotechnologies Announces Board Changes

      Adverum Biotechnologies Announces Board Changes

      MENLO PARK, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the appointment of Rekha Hemrajani, M.B.A., James Scopa, J.D., M.B.A., and Mark Lupher, Ph.D. to its Board of Directors, effective immediately...

      Read Full Article
    14. Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors

      Avenue Therapeutics Announces Appointment of Dr. Thomas G. Moore to Board of Directors

      NEW YORK, April 30, 2019 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today announced that Dr. Thomas G. Moore has been appointed to its Board of Directors...

      Read Full Article
    15. Former Citi Card CEO Jud Linville Joins Board of Directors for Amino Payments

      Former Citi Card CEO Jud Linville Joins Board of Directors for Amino Payments

      PHILADELPHIA, April 23, 2019 (GLOBE NEWSWIRE) -- Amino® Payments, the leading transparency and payments company for digital advertising, announced today that Jud Linville, most recently the CEO of Global Cards and Consumer Services at Citi since 2010, with 20 years of executive experience at American Express, has joined Amino’s Board of Directors...

      Read Full Article
    16. Sermonix Pharmaceuticals Adds Three New Members to Its Board of Directors

      Sermonix Pharmaceuticals Adds Three New Members to Its Board of Directors

      COLUMBUS, Ohio, April 23, 2019 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals LLC, a privately held biopharmaceutical company focused on the development and commercialization of female-specific oncology products, today announced the addition of Richard U. DeSchutter, Michael A. Friedman, M.D., and Stephen Rubino, Ph.D., to its board of directors...

      Read Full Article
    17. CohBar Announces the Appointment of David Greenwood to its Board of Directors

      CohBar Announces the Appointment of David Greenwood to its Board of Directors

      MENLO PARK, Calif., April 22, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today announced the appointment of David Greenwood to its Board of Directors...

      Read Full Article
    18. Identiv Nominates Retired U.S. Navy Vice Admiral Robin R. Braun for Election to Board of Directors

      Identiv Nominates Retired U.S. Navy Vice Admiral Robin R. Braun for Election to Board of Directors

      FREMONT, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Identiv, Inc. (NASDAQ: INVE), a global provider of physical security and secure identification, has announced that the Board of Directors has nominated Robin R. Braun to be elected as a director at the company's annual meeting of stockholders on May 29, 2019...

      Read Full Article
    1-24 of 214 1 2 3 4 5 6 7 8 9 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content